Podcasts about clinical practice

This week, we look at new trials on glucocorticoids for pneumonia in Africa, shunting for normal-pressure hydrocephalus, and pegcetacoplan for two rare kidney diseases. We review updated vaccine evidence for Covid-19, RSV, and influenza, and present a case of respiratory decline and muscle weakness. Perspectives explore health care incentives, U.S. global health strategy, and bringing AI-enabled care to rural America.

In this episode, we explore how artificial intelligence is transforming medical decision-making, clinical workflows, and patient outcomes. Our guest, Dr. Zafar Chaudry, Senior Vice President, Chief Digital Officer, and Chief AI & Information Officer at Seattle Children's, breaks down what a true human-AI partnership looks like inside modern healthcare. Watch the full video here. We discuss how AI is being used as a clinical co-pilot, supporting clinicians with faster access to medical knowledge, evidence-based guidelines, and real-time patient data. Dr. Chaudry shares real examples of AI improving diagnostic accuracy, enhancing patient safety, and enabling more personalized treatment plans. You'll also hear insights on the ethical considerations, accountability, and integration challenges that healthcare leaders need to understand as AI becomes more embedded in clinical practice. Topics covered in this episode: How AI supports medical decision-making and clinical workflows Real-world use cases where AI improves patient care and outcomes The role of AI in diagnostics, risk prediction, and personalized medicine Ethical considerations, transparency, and accountability in AI deployment How clinicians and AI can work together without losing the human touch What healthcare leaders should prioritize as AI adoption accelerates This episode is ideal for healthcare executives, clinicians, digital health leaders, and anyone navigating the rapidly evolving landscape of AI in healthcare. Listen to learn how organizations can responsibly and effectively integrate AI to enhance clinical practice and improve patient care. Connect with Dr. Chaudry on LinkedIn. Find Dr. Chaudry's work at https://www.seattlechildrens.org Subscribe and stay at the forefront of the digital healthcare revolution. Watch the full video on YouTube @TheDigitalHealthcareExperience The Digital Healthcare Experience is a hub to connect healthcare leaders and tech enthusiasts. Powered by Taylor Healthcare, this podcast is your gateway to the latest trends and breakthroughs in digital health. Learn more at taylor.com/digital-healthcare About Us: Taylor Healthcare empowers healthcare organizations to thrive in the digital world. Our technology streamlines critical workflows such as procedural & surgical informed consent with patented mobile signature capture, ransomware downtime mitigation, patient engagement and more. For more information, please visit imedhealth.com   The Digital Healthcare Experience Podcast: Powered by Taylor Healthcare Produced by Naomi Schwimmer  Hosted by Chris Civitarese Edited by Eli Banks Music by Nicholas Bach  

Robert Huckman is a professor of business administration at Harvard Business School and a research associate at the National Bureau of Economic Research. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. D.M. Cutler and R.S. Huckman. Has Corporatization Met Its Match? The Challenge of Making Money by Keeping People Healthy. N Engl J Med 2025;393:2177-2180.

The EAT–Lancet Commission 2025: Health, Sustainability, and Justice The updated EAT–Lancet Commission on Healthy, Sustainable, and Just Food Systems, published in 2025, marks a significant evolution in our understanding of how food connects health, the environment, and social justice. Learn more in today's episode, written by Dr. Shireen Kassam at Plant Based Health Professionals UK #vegan #plantbased #plantbasedbriefing #wfpb #plantbasednutrition #eatlancet #climatechange #climatediet #foodjustice ========================== Original post: https://plantbasedhealthprofessionals.com/review-of-the-plant-based-nutrition-and-lifestyle-medicine-news-october-2025  ========================== RELATED EPISODES: Use search field at PlantBasedBriefing.com/episodes  ========================== Plant-Based Health Professionals UK is an non-profit organization dedicated to providing education and advocacy on whole food plant-based nutrition and lifestyle medicine for prevention and treatment of chronic disease. In addition to practicing conventional medicine, they promote health and well-being using a plant-based lifestyle approach. They reaize there is no doubt that conventional medicine has resulted in some astonishing advances in patient care. However, the current model of healthcare in the UK focuses primarily on treating established disease, rather than emphasising interventions that could prevent or reduce the burden of chronic disease. They provide a valuable resource for the education of healthcare professionals and the general public alike and aim to empower individuals to take control of their own health. Dr. Shireen Kassam founded PBHP UK in 2018. She's a certified lifestyle medicine physician and author of the book, Eating Plant-Based, Scientific Answers to Your Nutrition Questions, co-authored with her sister Zahra, was published in January 2022. She has also co-edited the textbook Plant-Based Nutrition in Clinical Practice, published in September 2022. Learn more at https://plantbasedhealthprofessionals.com/  ============================== FOLLOW PLANT BASED BRIEFING ON: YouTube: https://www.youtube.com/@plantbasedbriefing     Spotify: https://open.spotify.com/show/2GONW0q2EDJMzqhuwuxdCF?si=2a20c247461d4ad7 Apple Podcasts: https://podcasts.apple.com/us/podcast/plant-based-briefing/id1562925866 Your podcast app of choice: https://pod.link/1562925866 Facebook: https://www.facebook.com/PlantBasedBriefing   LinkedIn: https://www.linkedin.com/company/plant-based-briefing/   Instagram: https://www.instagram.com/plantbasedbriefing/   

In this episode, Dr. Diane interviews Amardeep Bedi, a former optometrist who pivoted from clinical practice to practice enhancement coaching. Amardeep shares his journey of recognizing the need for change, the challenges he faced, and how he created Mastery Coaching to help other practice owners find fulfillment and success. The conversation emphasizes the importance of self-belief, personal growth, and the need to define success on one's own terms. Takeaways Amardeep Bedi transitioned from clinical optometry to coaching to find personal fulfillment. He recognized the importance of self-belief in achieving one's goals, where many clinicians feel bored and unfulfilled in their careers, leading to a desire for change. Mastery Coaching helps practice owners optimize their businesses for a better work-life balance. Taking time for self-reflection is crucial for personal and professional growth. Success should be defined on individual terms, not societal expectations. Amardeep emphasizes the need for kindness towards oneself during transitions. Building freedom into one's life is essential for happiness. The journey of pivoting can lead to greater impact and fulfillment. It's important to trust oneself and take the leap towards change.   MORE WAYS TO CONNECT: Follow our LinkedIn page:  https://www.linkedin.com/company/life-beyond-clinical-practice/    Book a Strategy Call with Dr Diane https://calendly.com/lbcp/strategy-call    Join the Movement on Instagram: @lifebeyondclinicalpractice  Rate and Review the show on Apple Podcasts https://podcasts.apple.com/us/podcast/life-beyond-clinical-practice-healthcare-careers-professional/id1713086617      Enjoyed this episode?  We think you'll enjoy this one too https://podcasts.apple.com/ca/podcast/102-why-loving-yourself-is-key-to-authentically-thriving/id1713086617?i=1000717138734       

Join legendary clinical herbalist Paul Bergner in an intimate, living-room conversation on herbalism as a calling, not just a career. With over 50 years of hands-on clinical practice, teaching, and mentorship, Paul shares rare insight into what truly shapes a great herbalist—diet, sleep, case-based learning, critical thinking, and deep relationship with plants. In this wide-ranging monologue, Paul reflects on: His early work in prisons and community clinics Why follow-ups matter more than textbooks How herbalists are really trained The role of "calling" in healing work Why the future of herbalism is becoming simpler, not more complex This is a masterclass in lived experience from one of the most influential medical herbalists of our time. WATCH THIS EPISODE ON YOUTUBE Learn more about Paul and his work | North American Institute of Medical Herbalism | NAIMH.com Herbalism in your neck of the woods. HerbRally | HerbRally.com DISCLAIMER This content is for educational and entertainment purposes only. It is not intended to diagnose, treat, or cure any disease. Always consult with a qualified healthcare provider before making changes to your health regimen.

This week, we look at new studies on early aspirin discontinuation after myocardial infarction, an antiviral pill for dengue prevention, and CRISPR-based gene editing for lipid disorders. We review bedside clinical teaching and present a complex case of seizures and visual disturbances. Perspectives explore antidepressant safety in pregnancy, restoring trust in public health, academic medical centers' venture investments, and a young physician's wrinkled white coat.

Nishant Uppal is an instructor in medicine at Massachusetts General Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. N. Uppal and Z. Song. Venture Capital Investments by U.S. Academic Medical Centers. N Engl J Med 2025;393:2077-2080.

Tricuspid Regurgitation: New Insights and Implications for Clinical Practice   Guest: Vidhu Anand, M.B.B.S. Host: Kyle Klarich, M.D.   This episode of Mayo Clinic's “Interviews With the Experts,” explores new insights into tricuspid regurgitation and its implications for clinical practice. Dr. Vidhu Anand discusses the dynamic nature of TR, its impact on prognosis, and the importance of close monitoring even when the condition appears to improve. The conversation highlights evolving guideline considerations, patient risk stratification, and how AI and machine learning may soon support earlier, more personalized interventions. Listeners will gain practical takeaways on when to escalate care and how to optimize long-term outcomes for TR patients.   Topics Discussed: How has our understanding of the natural history of tricuspid regurgitation changed, and what does this mean for the way we monitor and counsel patients? What are the current indications for intervention in isolated TR? How is TR currently classified? Are there any novel classifications based on patient's risk profile, since comorbidities play an important role in TR? Review of Mayo Clinic study using AI/machine learning and outcomes in TR.   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.

Send us a message with this link, we would love to hear from you. Standard message rates may apply.Clear guidance on benefits, risks, and how the FDA's label changes shift conversations in the exam room about HRTNikki's Corner• Philly's first Michelin stars and what the tiers mean• Flying taxis in Dubai • A cold case solved by college criminology studentsLearning • What HRT is, routes of therapy, and who benefits• Reframing WHI-era fears with age and timing data• FDA label changes and clinical implications• Contraindications and safer use considerations• Women's health bias and the cost of not listening• Practical steps for shared decisions with cliniciansReferencesThe 2022 Hormone Therapy Position Statement of the North American Menopause Society. Menopause (New York, N.Y.). 2022;29(7):767-794. doi:10.1097/GME.0000000000002028.Management of Menopausal Symptoms: A Review. Crandall CJ, Mehta JM, Manson JE. JAMA. 2023;329(5):405-420. doi:10.1001/jama.2022.24140.Hormone Therapy for Postmenopausal Women. Pinkerton JV. The New England Journal of Medicine. 2020;382(5):446-455. doi:10.1056/NEJMcp1714787.Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: US Preventive Services Task Force Recommendation Statement. Grossman DC, Curry SJ, Owens DK, et al. JAMA. 2017;318(22):2224-2233. doi:10.1001/jama.2017.18261.Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. Gartlehner G, Patel SV, Reddy S, et al. JAMA. 2022;328(17):1747-1765. doi:10.1001/jama.2022.18324.Hormone Therapy in the Postmenopausal Years: Considering Benefits and Risks in Clinical Practice. Genazzani AR, Monteleone P, Giannini A, Simoncini T. Human Reproduction Update. 2021;27(6):1115-1150. doi:10.1093/humupd/dmab026.Hormone Therapy in Menopause: Concepts, Controversies, and Approach to Treatment. Flores VA, Pal L, Manson JE. Endocrine Reviews. 2021;42(6):720-752. doi:10.1210/endrev/bnab011.The Women's Health Initiative Randomized Trials and Clinical Practice: A Review. Manson JE, Crandall CJ, Rossouw JE, et al. JAMA. 2024;331(20):1748-1760. doi:10.1001/jama.2024.6542.Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: US Preventive Services Task Force Recommendation Statement. Mangione CM, Barry MJ, NicSupport the showSubscribe to Our Newsletter! Production and Content: Edward Delesky, MD & Nicole Aruffo, RNArtwork: Olivia Pawlowski

Neste episódio do StrabCast, o Dr. Sean Donahue, um dos principais investigadores do PEDIG (Pediatric Eye Disease Investigator Group), revisita as evidências sobre exotropia intermitente e nos mostra como aplicá-las à prática clínica. Prepare-se — está imperdível! In this episode of StrabCast, Dr. Sean Donahue, one of the leading investigators from the PEDIG, takes us through the key evidence on intermittent exotropia — and how to bring it into real-world clinical practice. Don't miss it — this episode is a must-listen! 

What is consciousness, really - and why have centuries of science and philosophy still not resolved it? In this episode of Mind-Body Solution, Dr Tevin Naidu is joined by Dr Elly Vintiadis, philosopher at the intersection of mind, cognitive science, psychiatry, and metaphysics. Together, we explore the foundations, limits, and future of theories of consciousness - and why our scientific worldview may need a major conceptual upgrade.This episode is part of a special series in collaboration with the Mind-at-Large Project: a three-year international initiative, spanning conferences, films, and media, investigating consciousness and its role in reality. It seeks to challenge the prevailing materialist paradigm and expand our understanding of mind across scales, from neurons to ecosystems, from individuals to the cosmos itself. A collaboration between philosophers, scientists, and scholars rethinking the nature of consciousness, reality, and beyond. Mind-at-Large Abstract Submission Guidelines: https://ctr4process.org/mind-at-large/submit/TIMESTAMPS:(00:00) — Intro & Welcome(00:30) — Mind-at-Large: A Call for Submissions(03:30) — How Materialism Became Our Default(06:13) — A Brief History of the Mind–Body Debate(11:14) — Why We Have 360 Theories of Consciousness(12:08) — Do We Need a Conceptual Revolution?(16:12) — Clinical Practice & The Limits of Reductionism(17:47) — Why Society Wants “Quick Fix” Psychiatry(18:05) — Is Consciousness Fundamental or Emergent?(20:59) — Beyond the Brain: Embodiment & Electromagnetic Fields(22:49) — Why Theories of Consciousness Actually Matter(23:03) — Mental Disorders: Biological, Social, or Normative?(26:19) — Why Biomarkers in Psychiatry Keep Failing(29:07) — How Substance Metaphysics Misleads Us(34:00) — Phenomenal Variation & Altered States(39:05) — Philosophy's Job: Synthesizing the Ways of Knowing(41:14) — Introspection vs Experiment: Are Both Valid?(52:30) — Animal Minds, Moral Status & Personhood(1:07:42) — Cautious Pluralism & Open Questions(1:15:22) — ConclusionEPISODE LINKS:- Mind-at-Large Project Playlist: https://youtube.com/playlist?list=PLPacM28YkMQCHdQl2_3OvDmHPl6jJRJcz&si=MxhDoX6bJjkEzMXK- Mind-at-Large Project: https://mindatlargeproject.com- Mind-at-Large Abstract Submission Guidelines: https://ctr4process.org/mind-at-large/submit/- Elly's Website: https://ellyvintiadis.com/- Elly's X: https://twitter.com/EllyVintiadis- Elly's LinkedIn: https://www.linkedin.com/in/elly-vintiadis-21a78817/- Elly's Publications: https://scholar.google.com/citations?user=mV7LCQwAAAAJ&hl=enCONNECT:- Website: https://mindbodysolution.org - YouTube: https://youtube.com/@mindbodysolution- Podcast: https://creators.spotify.com/pod/show/mindbodysolution- Twitter: https://twitter.com/drtevinnaidu- Facebook: https://facebook.com/drtevinnaidu - Instagram: https://instagram.com/drtevinnaidu- LinkedIn: https://linkedin.com/in/drtevinnaidu- Website: https://tevinnaidu.com=============================Disclaimer: The information provided on this channel is for educational purposes only. The content is shared in the spirit of open discourse and does not constitute, nor does it substitute, professional or medical advice. We do not accept any liability for any loss or damage incurred from you acting or not acting as a result of listening/watching any of our contents. You acknowledge that you use the information provided at your own risk. Listeners/viewers are advised to conduct their own research and consult with their own experts in the respective fields.

Do you long for something deeper in your life? Are you innately drawn toward spirituality and curious about what you may find? Do you think we as humans are naturally wired to search for deeper meaning in our lives? Whether it be a walk in the woods, or through mediation or prayer, our guest today, Dr. Lisa Miller, believes that we are naturally able to tap into a heightened awareness of the world around us. We are able to cultivate circuits in our brains which help us to become more spiritually aware. By developing this awareness, we can begin to free ourselves from depression, anxiety, loss of creativity, and so much more. We can consider things from a more awakened, more elevated perspective. Dr. Miller believes when we feel depressed, this is an alert asking us for deeper spiritual exploration.    Dr. Miller is a professor in the Clinical Psychology Program at Teachers College, Columbia University, where she founded the Spirituality Mind Body Institute, the first Ivy League graduate program and research institute in spirituality and psychology. She has been with the Department of Psychiatry at Columbia University Medical School for more than a decade.    Dr. Miller is the NYT bestselling author of "The Spiritual Child" and her latest book is "The Awakened Brain." She is the Editor of the Oxford University Press Handbook of Psychology and Spirituality, Founding Co-Editor-in-Chief of the APA journal "Spirituality in Clinical Practice," an elected Fellow of The American Psychological Association (APA) and the two-time President of the APA Society for Psychology and Spirituality. A graduate of Yale University and University of Pennsylvania, she earned her doctorate under the founder of positive psychology, Martin Seligman, and she has served as Principal Investigator on multiple grant-funded research studies. Info: LisaMillerPhD.com.  

What defines excellence in cystic fibrosis clinical care? Peter Mogayzel discusses the latest therapeutic guidelines, managing pulmonary exacerbations, the role of home monitoring, and how multidisciplinary teams work together to support patients in leading full, active lives. Timestamps: 00:00 – Introduction 00:41 – Key guidelines 01:54 – Multisystem disease 02:32 – Pulmonary exacerbations 04:04 – Chronic medications 05:37 – Home monitoring 08:15 – Multidisciplinary care

Dr. Peter Addy, LPC, LMHC, integrates foundational set and setting concepts with core therapeutic competencies to support clinicians working with clients who use psychedelics while outlining ethical responses, harm reduction strategies, and ways to incorporate these experiences into ongoing treatment. Interview with Elizabeth Irias. Earn CE credit for listening to this episode by joining our low-cost membership for unlimited podcast CE credits for an entire year, with some of the strongest CE approvals in the country (APA, NBCC, ASWB, and more). Learn, grow, and shine with Clearly Clinical Continuing Ed by visiting https://ClearlyClinical.com.

This week, we look at new research on potassium optimization in patients with defibrillators, reducing antihypertensive therapy in nursing homes, an mRNA influenza vaccine, and belzutifan for rare neuroendocrine tumors. We review long QT syndrome and present a case of abnormal behavior and seizures in a young man. We also explore perspectives on primary care reform, tobacco cessation in HIV and tuberculosis care, corporate control in health care, and the simple power of compassion with ice cream.

Jane Zhu is an associate professor of medicine in the Division of General Internal Medicine at Oregon Health and Science University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.M. Zhu and H. Rooke-Ley. Regulating Corporate Control in Health Care — Oregon's Attempt to Revive the CPOM Doctrine. N Engl J Med 2025;393:1972-1974.

Read the article here: https://journals.sagepub.com/doi/full/10.1177/30494826251336314

Welcome to another episode of the Sustainable Clinical Medicine Podcast! In this episode, Dr. Sarah Smith sits down with Dr. Becket Mahnke, a pediatric cardiologist and seasoned Chief Medical Information Officer, to explore the evolving landscape of clinical informatics and practical strategies for making your clinical day more sustainable. Together, they dive into the complexities of electronic health record (EHR) systems—especially Epic—and discuss how thoughtful design, team-based approaches, and data-driven solutions can reduce physician burnout, enhance care efficiency, and foster more meaningful patient interactions. From leveraging AI-powered ambient dictation and chart summarization tools, to reimagining clinic workflows and setting healthy boundaries for clinicians, this conversation is packed with insights to help you reclaim time for yourself while delivering excellent patient care. Whether you're an EHR power user, an informatics enthusiast, or simply searching for ways to optimize your workday, you'll find actionable tips and a dose of inspiration in today's episode. Here are 3 key takeaways from this episode: Thoughtful EHR Design: Dr. Becket Mahnke emphasized that EHR systems, especially EPIC, are shaped by user requests—leading to many ways to do the same thing, but also plenty of opportunities to streamline workflows by standardizing processes at the organizational level. Teamwork for Efficiency & Wellness: Measuring teamwork (like tracking how many orders are started by team members rather than just physicians) can reveal powerful opportunities for redesigning clinical workflows. Taking a team-based approach relieves cognitive load and enables clinicians to spend more quality time with patients. AI & Ambient Documentation: Dr. Becket Mahnke shared how new AI-driven ambient dictation and chart summarization tools are true game changers, letting providers focus on real patient conversations—benefiting not just the clinician, but also the patient experience. Meet Dr. C. Becket Mahnke: Dr. C. Becket Mahnke is the Chief Medical Information Officer at Confluence Health and a practicing pediatric cardiologist. He is board‑certified in Clinical Informatics, an Epic‑certified Physician Builder, and serves on Epic's Physician Advisory Council. Under his leadership, Confluence Health has delivered measurable improvements in clinician experience—reducing EHR burden and after‑hours work, increasing patient portal adoption, and earning top‑quartile ARCH Collaborative EHR satisfaction, AMA Joy in Medicine™ Gold, and the WSMA Apple Award. His current focus is pragmatic, sustainable design and AI that protects clinician attention and improves care. You can find Dr. C. Becket Mahnke on: LinkedIn: www.linkedin.com/in/cbecketmahnke -------------- Would you like to view a transcript of this episode? Click Here **** Charting Champions is a premiere, lifetime access Physician only program that is helping Physicians get home with today's work done. All the proven tools, support and community you need to create time for your life outside of medicine. Learn more at https://www.chartingcoach.ca **** Enjoying this podcast? Please share it with someone who would benefit. Also, don't forget to hit “follow” so you get all the new episodes as soon as they are released. **** Come hang out with me on Facebook or Instagram. Follow me @chartingcoach to get more practical tools to help you create sustainable clinical medicine in your life. **** Questions? Comments? Want to share how this podcast has helped you? Shoot me an email at admin@reachcareercoaching.ca. I would love to hear from you.

This honest and reflective episode takes listeners inside the therapy room—where clinical learnings, vulnerability, and growth unfold in real time. Ms Catherine McGrath (Clinical Team Lead and Senior Psychologist) sharea hard-earned lessons from working with OCD clients using ERP (Exposure and Response Prevention), and open up about the emotional toll, missed opportunities, and the courage it takes to keep learning.From the power of self-compassion to the importance of holding space and involving parents in the therapeutic process, this conversation is a valuable reminder that clinicians don't need to be perfect to be effective—they just need to keep showing up.

Send us a textIn this episode of The Incubator Podcast, Ben and Daphna sit down with Dr. Alex Kemper, Division Chief of Primary Care Pediatrics at Nationwide Children's Hospital and Editor-in-Chief of Pediatrics. Dr. Kemper served as chair of the American Academy of Pediatrics subcommittee that authored the 2022 revision of the neonatal hyperbilirubinemia guidelines.Together, they explore the motivations behind revisiting the 2004 guideline, the major changes introduced, and how these revisions are shaping clinical care. Dr. Kemper explains why treatment thresholds for phototherapy were raised, the careful balance between avoiding unnecessary interventions and preventing kernicterus, and the rationale for moving away from the risk stratification nomogram. The discussion highlights phototherapy as an effective but not benign therapy—one that can disrupt bonding, prolong hospitalization, and create family stress when overused.Listeners will gain insight into the complexities of evidence review, the challenges of consensus-building over eight years of work, and the importance of shared decision-making and reliable follow-up after discharge. This conversation not only demystifies the new guidelines but also reframes the way clinicians think about jaundice management, risk stratification, and the broader impact on families.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Episode 322 hosts Dr Mustafa Narwan (Plastic Surgeon from Germany & UAE) This is the fifth of several episodes recorded at ICCE (International Cosmetic Congress and Exhibition) in Cairo, Egypt. Dr Jake and David were honoured to be invited to the event in September 2025 and in doing so, IA became the first podcast in the world to be resident at an aesthetic conference.  In Chapter 5 of these episodes we explore the concepts of biohacking and integrating a holistic approach to patients. Mustafa shares his insights on combining different treatments to cater to individual patient needs, the significance of thorough consultations, and the role of lifestyle modifications like exercise, diet, and sleep in preparing for and recovering from surgery.  00:00 Introduction 00:17 Podcast Purpose and Disclaimer  01:03 Introducing Dr. Mustafa Narwan 01:45 Mustafa's Background and Clinics 02:27 Holistic Medicine Explained 05:34 Consultation Process and Patient Care 11:30 The Importance of Biohacking 13:32 Daily Health Routine and Habits 21:33 Understanding Your Body's Needs 22:18 Dealing with Jet Lag 24:00 Patreon and Community Engagement 25:19 Supplement Regimen for Health and Longevity 29:42 Integrating Biohacking into Clinical Practice 31:09 Controversial Peptides and Scientific Backing 33:25 Common Misconceptions in Aesthetic Treatments 34:34 Personal Insights and Future Goals 36:00 Concluding Thoughts and Farewell JOIN OUR ONLINE COMMUNITY FOR EDUCATION & NETWORKING OPPORTUNITIES CLICK HERE TO BROWSE OUR IA OFFERS FOR DISCOUNTS & SPECIALS CLICK HERE IF YOU'RE A BRAND OR COMPANY & WANT TO WORK WITH US CLICK HERE TO APPLY TO BE A GUEST ON OUR PODCAST CONTACT US

In this episode, we look at new trials on deferring arterial catheterization in shock, beta-blocker use after myocardial infarction, and a treatment for triple-negative breast cancer. We review acromegaly. A case describes a man with dyspnea, edema, and pacemaker lead displacement. We explore perspectives on the burdens of primary care, the erosion of harm reduction, child health policy, and the meaning of hospice.

Joshua Barocas is an associate professor of medicine at the University of Colorado Anschutz Medical Campus. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.A. Barocas. The Erosion of Harm Reduction. N Engl J Med 2025;393:1865-1867. B.A. Barsky, A. Caplan-Bricker, and C. Robertson. Religious Liberty as a Shield for Public Health — The Case of Overdose-Prevention Centers. N Engl J Med 2025;393:1867-1869.

Welcome to the Plant Cunning Podcast! Today, we are thrilled to chat with Richard Mandelbaum, an herbalist, teacher, writer and one of the founders of ArborVitae School of Traditional Herbalism (https://www.arborvitaeny.com/). You can find him at https://www.richardmandelbaum.com/. In this episode, Richard shares his journey into the world of plants and herbalism, his experiences studying botany, and his insights into clinical herbalism. We delve into the importance of slowing down and truly observing the plants around us, the nuances of plant energetics, and the value of crossing scientific and traditional herbalist knowledge. Richard also talks about the dynamics of teaching field botany, working with clients, and the recent exploration of mosses.00:00 Introduction to the Plant Cunning Podcast00:31 Guest Introduction: Richard Mandelbaum00:53 The Herbal Community and Mutual Aid03:27 Richard's Journey to the Plant Path12:14 Learning and Teaching Field Botany27:21 Challenges in Plant Identification30:03 Working with Hawthorne in Herbal Practice36:22 Understanding Herbal Energetics38:13 Discovering Herbalism and Integrating Science38:43 The Value of Multiple Perspectives in Medicine40:41 Astrology and Energetic Systems41:59 Clinical Practice and Herbal Formulation45:53 Challenges in Mainstream Medicine51:44 The Importance of Clinical Experience01:00:28 Reflections on Field Botany01:09:17 Current Practice and Teaching01:13:04 Final Thoughts and Upcoming Events

Want to share your feedback? Send us a message!Dr. Shahriar SheikhBahaei, Assistant Professor of Neurobiology and Behavior at Stony Brook University, joins host Sara MacIntyre, M.A., CCC-SLP, to discuss emerging research exploring the cellular and neurobiological mechanisms underlying stuttering. Dr. SheikhBahaei shares his journey from lived experience with stuttering to leading a neuroscience research lab investigating how glial cells, particularly astrocytes, contribute to motor control and speech-related circuits.The conversation delves into several recent studies from his lab that utilize mouse models to uncover how alterations in astrocyte function and iron regulation may relate to the neural pathways involved in stuttering. Dr. SheikhBahaei walks listeners through the background, scientific rationale, and key findings of these studies, highlighting what they reveal about the non-vocal motor aspects of stuttering and how this basic science may inform future directions in understanding and treatment.The episode concludes with reflections on bridging laboratory research with the lived experiences of people who stutter and fostering collaboration among scientists, clinicians, and the stuttering community.Resources discussed:SheikhBahaei, S., et al. (2025). Non-vocal motor deficits in a transgenic mouse model linked to stuttering disorders. bioRxiv. https://www.biorxiv.org/content/10.1101/2025.08.08.669441v2SheikhBahaei, S., et al. (2025). Iron dysregulation in mice engineered with a mutation associated with stuttering. bioRxiv. https://www.biorxiv.org/content/10.1101/2025.07.30.667752v1SheikhBahaei, S., et al. (2024). Scientists, society, and stuttering: A multi-stakeholder approach. International Journal of Clinical Practice. https://onlinelibrary.wiley.com/doi/full/10.1111/ijcp.13678Shahriar SheikhBahaei, Ph.D., is a neuroscientist and faculty member at Stony Brook University. His research focuses on how the brain controls complex motor behaviors such as speech and breathing, particularly focusing on the role of astrocytes in neural circuits. Growing up with stuttering has influenced his lifelong pursuit to understand the neurobiology of speech and communication. He completed his Ph.D. in Neuroscience through a joint program at University College London and the National Institutes of Health (NIH). He later became one of the first Independent Research Scholars at NIH, where he established his own lab. At Stony Brook University, he continues to investigate the cellular and circuit foundations of speech disorders while also mentoring the next generation of scientists and advocating for more inclusive perspectives on communication.

Overview: In this episode, Dr Joel Gallant gives a history of antiretroviral therapy and HIV drug resistance, drawing on his personal and professional experience beginning in the early 1980s. The views expressed are those of the panelist and not necessarily Gilead Sciences, Inc. The information provided in this podcast is not intended to be and should not be understood to provide medical advice. Listeners should note that our discussions in this episode are relevant to the USA only and may not be appropriate for other regions. This episode was recorded in August 2023 and the content reflects the information available at that time. Guest: Joel Gallant, MD, MPH    For more information, please visit: https://www.pri-med.com/clinical-resources/curriculum/hiv-in-focus    References AIDSVu.org. New HIV diagnoses. 2023. Available from: https://aidsvu.org/local-data/united-states/south/ (Accessed May 19, 2025) AIDSVu.org was developed by the Rollins School of Public Health at Emory University in partnership with Gilead Sciences, Inc. Alonso A, de Irala J. Strategies in HIV prevention: the A-B-C approach. Lancet 2004;364:1033. Available from: https://doi.org/10.1016/s0140-6736(04)17050-5 Bacheler L, Jeffrey S, Hanna G et al. Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy. J Virol 2001;75:4999–5008. Available from: https://doi.org/10.1128/jvi.75.11.4999-5008.2001 Barré-Sinoussi F, Chermann JC, Rey F et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220:868–71. Available from: https://doi.org/10.1126/science.6189183 Bayer R, Edington C. HIV testing, human rights, and global AIDS policy: exceptionalism and its discontents. J Health Polit Policy Law 2009;34:301–23. Available from: https://doi.org/10.1215/03616878-2009-002 Centers for Disease Control and Prevention. Pneumocystis pneumonia – Los Angeles. MMWR Morb Mortal Wkly Rep 1981;30:250-2. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/june_5.htm Centers for Disease Control and Prevention. Preventing HIV. 2024. Available from: https://www.cdc.gov/hiv/prevention/index.html (Accessed May 22, 2025) Cohen MS, Chen YQ, McCauley M et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493–505. Available from: https://doi.org/10.1056/NEJMoa1105243 Cuevas JM, Geller R, Garijo R et al. Extremely high mutation rate of HIV-1 in vivo. PLoS Biol 2015;13:e1002251. Available from: https://doi.org/10.1371/journal.pbio.1002251 Department of Health and Human Services. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. 2024. Available from: https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/optimizing-antiretroviral-therapy (Accessed May 19, 2025) Dragovic G. Acute pancreatitis in HIV/AIDS patients: an issue of concern. Asian Pac J Trop Biomed 2013;3:422–425. Available from: https://doi.org/10.1016%2FS2221-1691(13)60091-X Eron JJ, Benoit SL, Jemsek J et al. Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party. N Engl J Med 1995;333:1662–9. Available from: https://doi.org/10.1056/nejm199512213332502 Gandhi RT, Tashima KT, Smeaton LM et al. Long-term outcomes in a large randomized trial of HIV-1 salvage therapy: 96-week results of AIDS clinical trials group A5241 (OPTIONS). J Infect Dis 2020;221:1407–15. Available from: https://doi.org/10.1093/infdis/jiz281 Getting to Zero San Francisco. HIV epidemiology annual report 2017. 2022. Available from: https://gettingtozerosf.org/getting-to-zero-resources/hiv-report-2017/ (Accessed May 22, 2025) Global Fund. About the Global Fund. 2024. Available from: https://www.theglobalfund.org/en/about-the-global-fund/ (Accessed May 19, 2025) Gulick RM, Lalezari J, Goodrich J et al. Maraviroc for previously treated patients with R5 HIV-1 infection. N Engl J Med 2008;359:1429–41. Available from: https://doi.org/10.1056/NEJMoa0803152 Gulick RM, Mellors JW, Havlir D et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997;337:734–9. Available from: https://doi.org/10.1056/nejm199709113371102 Haubrich R, Berger D, Chiliade P et al. Week 24 efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients. AIDS 2007;21:F11–8. Available from: https://doi.org/10.1097/QAD.0b013e3280b07b47 HIV Prevention Trials Network. HPTN 052. 2023. Available from: https://www.hptn.org/research/studies/hptn052 (Accessed May 19, 2025) HIV.gov. HIV and AIDS timeline. 2024. Available from: https://www.hiv.gov/hiv-basics/overview/history/hiv-and-aids-timeline/ (Accessed May 19, 2025) HIVinfo.NIH.gov. FDA approval of HIV medicines. 2024. Available from: https://hivinfo.nih.gov/understanding-hiv/infographics/fda-approval-hiv-medicines (Accessed May 19, 2025) i-base. Cross-resistance by drug class. 2025. Available from: https://i-base.info/guides/changing/cross-resistance (Accessed May 19, 2025) Iyidogan P, Anderson KS. Current perspectives on HIV-1 antiretroviral drug resistance. Viruses 2014;6:4095–139. Available from: https://doi.org/10.3390/v6104095 Lalezari JP, Henry K, O'Hearn M et al. Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America. N Engl J Med 2003;348:2175–85. Available from: https://doi.org/10.1056/NEJMoa035026 Landovitz RJ, Donnell D, Clement ME et al. Cabotegravir for HIV prevention in cisgender men and transgender women. N Engl J Med 2021;385:595–608. Available from: https://doi.org/10.1056/NEJMoa2101016 Larder BA, Darby G, Richman DD. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 1989;243:1731–4. Available from: https://doi.org/10.1126/science.2467383 Lau B, Gange SJ, Moore RD. Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells/mm3. J Acquir Immune Defic Syndr 2007;44:179–87. Available from: https://doi.org/10.1097/01.qai.0000247229.68246.c5 Lucas C. The San Francisco model and the nurses of Ward 5B. Lancet HIV 2019;6:E819. Available from: https://doi.org/10.1016/S2352-3018(19)30267-X Madruga JV, Cahn P, Grinsztejn B et al. Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial. Lancet 2007;370:29–38. Available from: https://doi.org/10.1016/s0140-6736(07)61047-2 Marcelin AG. Resistance to nucleoside reverse transcriptase inhibitors. In: Geretti AM, editor. Antiretroviral Resistance in Clinical Practice. London: Mediscript; 2006. Chapter 1. Available from: https://www.ncbi.nlm.nih.gov/books/NBK2241/ Margolis AM, Heverling H, Pham PA et al. A review of the toxicity of HIV medications. J Med Toxicol 2014;10:26–39. Available from: https://doi.org/10.1007/s13181-013-0325-8 Moore RD, Creagh-Kirk T, Keruly J et al. Long-term safety and efficacy of zidovudine in patients with advanced human immunodeficiency virus disease. Zidovudine Epidemiology Study Group. Arch Intern Med 1991;151:981–6. Available from: https://doi.org/10.1001/archinte.1991.00400050123023 National Institute of Allergy and Infectious Diseases. HIV Undetectable = Untransmittable (U = U), or treatment as prevention. 2019. Available from: https://www.niaid.nih.gov/diseases-conditions/treatment-prevention (Accessed May 19, 2025) Nelson MR, Katlama C, Montaner JS et al. The safety of […] for the treatment of HIV infection in adults: the first 4 years. AIDS 2007;21:1273–81. Available from: https://doi.org/10.1097/QAD.0b013e3280b07b33 New York State Department of Health. Pre-exposure prophylaxis (PrEP) to prevent HIV infection: question and answers. 2012. Available from: https://www.health.ny.gov/publications/0265/ (Accessed May 22, 2025) Overton ET, Richmond G, Rizzardini G et al. Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with human immunodeficiency virus 1 type 1 infection: 152-week results from ATLAS-2M, a randomized, open-label, phase 3b, noninferiority study. Clin Infect Dis 2023;76:1646–54. Available from: https://doi.org/10.1093/cid/ciad020 Pollak EB, Parmar M. Indinavir. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554396/ (Accessed May 19, 2025) Richman DD, Fischl MA, Grieco MH et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med 1987;317:192–7. Available from: https://doi.org/10.1056/nejm198707233170402 Schmit JC, Ruiz L, Clotet B et al. Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538). AIDS 1996;10:995–9. Available from: https://doi.org/10.1097/00002030-199610090-00010 Siliciano JD, Kajdas J, Finzi D et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat Med 2003;9:727–8. Available from: https://doi.org/10.1038/nm880 Steigbigel RT, Cooper DA, Kumar PN et al. Raltegravir with optimized background therapy for resistant HIV-1 infection. N Engl J Med 2008;359:339–54. Available from: https://doi.org/10.1056/NEJMoa0708975 TIME. Man of the year. 1996. Available from: https://time.com/vault/issue/1996-12-30/page/1/ (Accessed May 19, 2025) U.S. President's Emergency Plan for AIDS Relief (PEPFAR). About us. 2025. Available from: https://www.state.gov/about-us-pepfar/ (Accessed May 19, 2025)

Anesthesiology 2025 Desiree Chappell and Mike Grocott discuss the latest advancements and key topics in the field of anesthesiology with special guests Sheila Barnett, Chair of the Department of Anesthesiology at Dartmouth Hitchcock Medical Center, Professor of Anesthesiology at Geisel School of Medicine at Dartmouth and Patrick Guffey, Professor of Clinical Practice, Anesthesiology-Pediatric Anesthesiology at the University of Colorado Anschutz Medical Campus. The conversation centers around the Anesthesia Quality Institute (AQI) and its various initiatives, including the National Anesthesia Clinical Outcomes Registry (NACO) and the importance of integrating electronic health records for improved data collection and quality of care. The guests highlight the challenges and opportunities of using clinical data to drive quality improvements and the future potential of collaborating with electronic health record systems like Epic. The episode underscores the importance of quality data in anesthesia and highlights efforts to enhance patient outcomes and healthcare value.

In 1865, German physician and medical writer Justus Hecker published a volume titled The Epidemics of the Middle Ages. In a footnote, he remarked on a strange phenomenon: an outbreak of meowing nuns. In this minisode, I bring you the story of the meowing nuns of late medieval France and the men who told their story.Researched, written, and produced by Corinne Wieben with original music by Purple Planet.SourcesPrimaryAristotle. History of Animals. Translated by d' A. W. Thompson. In Aristotle, Complete Works. Vol. 1, 774–993. Princeton, NJ: Princeton University Press, 1984.Aristotle. Politics. Translated by Ernest Barker. Oxford: Oxford University Press, 1977.Hecker, J. F. C. The Epidemics of the Middle Ages. Translated by B. G. Babington. London: Woodfall, 1844. Zimmerman, J. G. Solitude. Vol. II. London: Dilly, 1798.SecondaryBartholomew, Robert E. Little Green Men, Meowing Nuns and Head-Hunting Panics: A Study of Mass Psychogenic Illness and Social Delusion. London: McFarland, 2001.Bartholomew, Robert E. and Simon Wessely. “Protean Nature of Mass Sociogenic Illness: From Possessed Nuns to Chemical and Biological Terrorism Fears.” British Journal of Psychiatry 180, no. 4 (2002): 300–306.Mercer, Christia. “The Philosophical Roots of Western Misogyny.” Philosophical Topics 46, no. 2 (2018): 183–208.Penso G. Roman Medicine. 3rd ed. Noceto: Essebiemme, 2002.Tasca, Cecilia et al. “Women and Hysteria in the History of Mental Health.” Clinical Practice and Epidemiology in Mental Health 8 (2012): 110-9.Support the showEnchantedPodcast.netBluesky/enchantedpodcast.net

In this episode, we discuss long-term outcomes after chest-wall irradiation for breast cancer, new treatments for psoriasis and obesity, and early results on a vaccine for Lassa fever. We review opioid deprescribing and a clinical case describes spiraling into a distant past. Perspectives examine the corporatization of health care, the health effects of new energy legislation, and Medicaid cuts affecting U.S. children.

Yashaswini Singh is an assistant professor of health services, policy, and practice at Brown University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. Y. Singh. The Antitrust Antidote to Hospital and Nursing Home Corporatization — Promises and Pitfalls. N Engl J Med 2025;393:1761-1764.

How much do you know about new therapies for treating fibrosis in MASH and the patients who can benefit most from them? Credit available for this activity expires: 10/29/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003068?ecd=bdc_podcast_libsyn_mscpedu

The November 2025 Recall revisits four insightful episodes centered on muscle and neuromuscular diseases. Kicking off the episode is a two-part series on myositis, where Dr. Stacey Clardy speaks with Dr. Andrew Mammen. The episode continues with an interview featuring Dr. Eric Voorn, who discusses the effectiveness of combining personalized, home-based aerobic exercise with coaching to improve physical fitness in individuals with neuromuscular diseases. The episode wraps up with Dr. Elia Sechi discussing the critical role of interpreting lab test results, understanding assay performance, and recognizing the real-world impact of false positives in myasthenia gravis diagnostics.  Podcast links: Updates on All Things Myositis – Part 1  Updates on  All Things Myositis - Part 2 Efficacy of Aerobic Exercise and Coaching on Physical Fitness in Neuromuscular Disease  False Positivity of Acetylcholine Receptor Autoantibodies in Clinical Practice Article links: Efficacy of Combined Aerobic Exercise and Coaching on Physical Fitness in People With Neuromuscular Diseases Risk of False Acetylcholine Receptor Autoantibody Positivity by Radioimmunoprecipitation Assay in Clinical Practice Show citations:  Oorschot S, Brehm MA, van Groenestijn AC, et al. Efficacy of Combined Aerobic Exercise and Coaching on Physical Fitness in People With Neuromuscular Diseases: A Randomized Clinical Trial. Neurology. 2025;105(1):e213781. doi:10.1212/WNL.0000000000213781 Zara P, Chessa P, Deiana GA, et al. Risk of False Acetylcholine Receptor Autoantibody Positivity by Radioimmunoprecipitation Assay in Clinical Practice. Neurology. 2025;104(9):e213498. doi:10.1212/WNL.0000000000213498 Disclosures can be found at Neurology.org.   

The Grayken Center for Addiction at Boston Medical Center's Behind the Evidence podcast is pleased to host "Behind the Masthead," a special series of episodes featuring conversations with addiction journal editors and other scholars on navigating current threats to addiction science and academic freedom. As the primary means of knowledge dissemination in the field, addiction journals are likely to be substantially impacted by the recent drastic changes to the federal funding of medical and public health research in the US. Through conversations with the editors of our field's leading scientific journals—as well as data scientists and other scholars—this series will offer addiction research professionals of all career stages the opportunity to learn valuable strategies for preserving the momentum and integrity of their research.Episode 1 is out now. Guest host Casy Calver, PhD interviews Alex Walley, MD and Emily Williams, PhD—two editors of the Grayken Center's journal, Addiction Science & Clinical Practice.Behind the Evidence is the addiction medicine podcast of the Grayken Center for Addiction at Boston Medical Center, and a project of the Center's free bimonthly newsletter Alcohol, Other Drugs, and Health: Current Evidence (AODH). This special series, “Behind the Masthead,” is guest-hosted by Casy Calver, PhD.Behind the Evidence hosts: Honora L. Englander, MD and Marc R. Larochelle, MDProduction: Raquel Silveira, MBAEditing: Casy Calver, PhDMusic and cover art: Mary Tomanovich, MAMiriam Komaromy, MD is the Executive Director of the Grayken Center for Addiction, and co-Editor-in-Chief of AODH, together with David Fiellin, MDLearn more about AODH and subscribe for free at www.aodhealth.org“Behind the Evidence” is supported by the Grayken Center for Addiction at Boston Medical Center. It is intended for educational purposes only, and should not be considered medical advice. The views expressed here are our own, and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.

The Grayken Center for Addiction at Boston Medical Center's Behind the Evidence podcast is pleased to host "Behind the Masthead," a special series of episodes featuring conversations with addiction journal editors and other scholars on navigating current threats to addiction science and academic freedom. As the primary means of knowledge dissemination in the field, addiction journals are likely to be substantially impacted by the recent drastic changes to the federal funding of medical and public health research in the US. What can we learn from the perspectives of addiction journal editors and other scholars in this moment of uncertainty?In this first episode of the “Behind the Masthead” series, guest host Casy Calver, PhD speaks with Alex Walley, MD and Emily Williams, PhD—two editors of the Grayken Center's journal, Addiction Science & Clinical Practice—on the lessons we can learn from the resilience of people who use drugs, to navigating changes to the NIH's public access policy.Behind the Evidence is the addiction medicine podcast of the Grayken Center for Addiction at Boston Medical Center, and a project of the Center's free bimonthly newsletter Alcohol, Other Drugs, and Health: Current Evidence (AODH). This special series, “Behind the Masthead,” is guest-hosted by Casy Calver, PhD.Behind the Evidence hosts: Honora L. Englander, MD and Marc R. Larochelle, MDProduction: Raquel Silveira, MBAEditing: Casy Calver, PhDMusic and cover art: Mary Tomanovich, MAMiriam Komaromy, MD is the Executive Director of the Grayken Center for Addiction, and co-Editor-in-Chief of AODH, together with David Fiellin, MDLearn more about AODH and subscribe for free at www.aodhealth.org“Behind the Evidence” is supported by the Grayken Center for Addiction at Boston Medical Center. It is intended for educational purposes only, and should not be considered medical advice. The views expressed here are our own, and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.

What if the monsters that haunt us at night aren't supernatural at all, but reflections of our own minds? In this episode of The Aging Well Podcast, Dr. Jeff Armstrong sits down with clinical psychologist Dr. Brian A. Sharpless to explore the fascinating intersection of sleep, anxiety, and fear.With decades of clinical experience, Dr. Sharpless has studied both common and rare sleep disorders—from insomnia and night terrors to the little-known “exploding head syndrome.” Drawing from his book Monsters on the Couch and years of research, he shares how anxiety, trauma, and unresolved inner conflict often shape what keeps us awake at night.Together, they unpack how sleep disturbances affect not just our nights but also our long-term health and aging. You'll also hear why understanding fear and the unconscious mind can help us move toward better sleep, stronger mental health, and ultimately, aging well.Learn more about Dr. Sharpless at https://briansharpless.com/BUY Monsters on the Couch and other books by Dr. Brian A. Sharpless on Amazon and support this podcast:Monsters on the Couch: The Real Psychological Disorders Behind Your Favorite Horror Movies https://amzn.to/4n3yYpjSleep Paralysis: Historical, Psychological, and Medical Perspectives https://amzn.to/41rWYdsUnusual and Rare Psychological Disorders: A Handbook for Clinical Practice and Research https://amzn.to/46beXYdPsychodynamic Therapy Techniques: A Guide to Expressive and Supportive Interventions https://amzn.to/3JvGsTMPlease, support The Aging Well Podcast by hitting the ‘like' button, subscribing/following the podcast, sharing with a friend, and….BUY the products you need to… age well from our trusted affiliates and support the mission of The Aging Well Podcast*.The Aging Well Podcast merchandise | Show how you are aging well | Use the promo code AGING WELL for free shipping on orders over $75 | https://theagingwellpodcast-shop.fourthwall.com/promo/AGINGWELLRebalance Health | products created by hormone health experts to lower cortisol, improve sleep, and minimize the impact of stress on the body and mind | https://get.aspr.app/SH1AkZ or https://rebalancehealth.com with the promo code: AGING WELLAuro Wellness | Glutaryl—Antioxidant spray that delivers high doses of glutathione (“Master Antioxidant”) | 10% off Code: AGINGWELL at https://aurowellness.com/agingwellpodcastBerkeley Life | Optimize nitric oxide levels | Purchase your starter kit at a 15% discount | Use the promo code: AGINGWELL15 | https://berkeleylife.pxf.io/c/6475525/3226696/31118Oxford Healthspan | Primeadine®,a plant-derived spermidine supplement | 10% off code: AGINGWELL | https://oxford-healthspan.myshopify.com/AgingWellJigsaw Health | Trusted supplements. “It's fun to feel good.” | Click the following link for 10% off: https://www.jigsawhealth.com/?rfsn=8710089.1dddcf3&utm_source=refersion&utm_medium=affiliate&utm_campaign=8710089.1dddcf3Prolon | The Fasting Mimicking Diet (FMD) is a revolutionary five-day nutrition program scientifically formulated to mimic the effects of a prolonged water fast while still allowing nourishment - supporting the benefits of fasting without the challenges and risks that come from water-only fasts. | For the best available discount always use this link: ⁠https://prolonlife.com/theagingwellpodcastThrive25—Your personal longevity advisor | https://www.thrive25.com/early-access?via=william-jeffrey Fusionary Formulas | Combining Ayurvedic wisdom with Western science for optimal health support. | 15% off Code: AGINGWELL | https://fusionaryformulas.com?sca_ref=9678325.IHg5xYhdOzzke8ZrDr Lewis Nutrition | Fight neurodegeneration and cognitive decline with Daily Brain Care by Dr Lewis Nutrition—a provendaily formula designed to protect and restore brain function. | 10% off code: AGINGWELL or use the link: https://drlewisnutrition.com/AGINGWELL*We receive commission on these purchases. Thank you.

This week, we look at new findings from the European prostate cancer screening study, advances in lung cancer therapy, physical therapy for meniscal tear, and a promising vaccine for Salmonella Paratyphi A. We review noninvasive liver fibrosis assessment and a complex clinical case, and explore perspectives on concierge care, kidney disease equity, WIC enrollment, community health, FDA regulation, and standing with colleagues in Gaza.

In this episode of SurgOnc Today, the SSO HPB disease site working group reviews strategies for implementation of histothripsy ablation in the management of liver primary and secondary malignancies, including a discussion of the evidence supporting it and support from the IDEAL framework for the adoption of surgical innovations into clinical practice. To do so, Drs. Miral Sadaria Grandhi and Zhi Ven Fong, members of the HPB disease site working group, are joined by Drs. Hop Tran Cao, Brock Hewitt, and Jeffrey Barkun.

Imagine a world where your voice holds the key to early disease detection, where a simple conversation can offer objective insights into your health. Join us as Henry O'Connell shares the inspiring journey of Canary Speech, transforming how clinicians understand and treat a spectrum of conditions.Chapter Summary:00:00 Introducing Henry O'Connell and Canary Speech02:08 The Genesis of Canary Speech06:56 How Canary Speech Technology Works12:05 Impact of Age, Gender, and Multimodal Analysis16:22 Diverse Applications and Real-Time Results20:29 Future Vision and Integration in Healthcare25:50 Addressing Ethical Concerns and Data Security30:08 Clinical Integration and Objective Pain Measurement34:51 The Impact on Clinical Practice and Patient Outcomes39:52 AI's Frontier: Speech, Multimodal Data, and LLMs43:55 Minimizing Errors and Enhancing Diagnostics47:18 Language Adaptability and Early Detection51:04 Remembering Jeff Adams and Contact InformationFeatured Quotes:“I'd always wanted to apply speech and language to the analysis of human condition and disease.” - Henry O'Connell“We could be returning four or five different scores like a blood profile, the voice profile.” - Henry O'Connell“It's helping us be the doctors we were trained to be.” - Henry O'ConnellBehind the Story:Henry O'Connell recounts the 40-year friendship with co-founder Jeff Adams, a pioneer in speech technology, whose vision to apply speech analysis to human health laid the foundation for Canary Speech. From deciphering Cold War spy messages to building Dragon Naturally Speaking and the Amazon Echo, Adams' expertise combined with O'Connell's experience in corporate turnarounds brought their shared dream to life. The company, even named by O'Connell's daughter, now stands at the forefront of medical innovation, using speech to objectively measure indicators of various diseases.Learn more about Canary Speech and their advancements in AI speech technology at www.canaryspeech.com.Connect With Henry O'Connell:Email: henry@canaryspeech.comCanary Speech Website: https://www.canaryspeech.com/Get In Touch!rob@2docstocpodcast.com

This promotional podcast has been initiated and funded by Merck, and a Merck product will be discussed. The intended audience is multiple sclerosis healthcare professionals in the UK only. The comments of the speakers in this podcast reflect their own opinions and are not necessarily those of Merck.

With a calcium score of zero, is there any fat in your diet?  Are there any recommended supplements for IBS?What is the safest and most appropriate dose of vitamin D3 for most seniors?

INFINITY Study on the timing of thyroid medication ingestionI have a growth near my eye that is changing in color and becoming crusty. What should I do?I've been suffering from hip pain for the last three years. Any suggestions on what to do?Could toxic exposures like mold cause conditions like low thyroid or autoimmunity?

Send us a textIn this episode of At the Bench, Betsy Crouch and David McCulley engage in a thought-provoking conversation with Dr. Eleanor Molloy, a neonatologist and physician scientist. They explore Eleanor's journey in neonatology, the importance of inflammation in neonatal health, and the challenges and rewards of conducting research in this field. The discussion also highlights the significance of collaboration, both within research teams and with parents, to enhance clinical practice and improve outcomes for neonates. Eleanor shares insights on the role of biomarkers, the impact of sex differences in research, and the necessity of international collaboration in pediatric research. The episode concludes with reflections on the balance between clinical work and research, the importance of community in academia, and the need for a rallying call to inspire the next generation of clinician scientists.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

In this episode, we look at new research on mucoactive therapy for bronchiectasis, aspirin use in anticoagulated patients with coronary disease, and sotatercept for early pulmonary arterial hypertension. We explore the genetics behind misdiagnosed common diseases and review uncertainty in medical training. We also share a case of woman with abdominal distention, edema, and pleural effusions and Perspectives on sickle cell disease, fetal personhood, and living with a genetic diagnosis.

Eberechi Nwogu-Onyemkpa is an assistant professor in the Division of Palliative Medicine at Washington University in St. Louis. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E. Nwogu-Onyemkpa and Others. Involving Palliative Care to Improve Outcomes in Sickle Cell Disease. N Engl J Med 2025;393:1553-1556. E. Costa and Others. Thirty Years of Hydroxyurea for Sickle Cell Anemia — Scientific Progress, Global Health Gaps. N Engl J Med 2025;393:1556-1559.

In this episode, we explore psychedelic-assisted therapy in clinical practice, examining how these treatments differ fundamentally from traditional pharmacotherapy. Can psychiatrists reconcile mystical experiences with evidence-based medicine while navigating the complex therapeutic paradigm of preparation, 8-hour sessions, and integration work? Faculty: Franklin King, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CMEs: Use of Psychedelic Drugs in Psychiatry Psychedelic-Assisted Therapy in Clinical Practice

In this episode, we look at new research in cervical cancer, lupus, gene therapy for immune deficiency, and malaria prevention in infants. We review hair loss in women, follow a case of tuberculosis in advanced HIV, and hear perspectives on vaccines, primary care, digital health, infection surveillance, AI in disaster response, Medicare policy, and bearing witness in conflict zones.

Michael Liu is a resident physician at Brigham and Women's Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. M. Liu, K.T. Kadakia, and R.K. Wadhera. Proliferation of Prior Authorization in Traditional Medicare — None the WISeR? N Engl J Med 2025;393:1457-1459.

 Ever wondered if your gut health protocols are truly helping, or possibly harming, your microbiome? Join Lindsey Parsons and Dr. Brad Leech as they unpack the latest science on antimicrobials, microbiome testing, leaky gut, low stomach acid, prebiotics and more. Discover when to use certain interventions, how to protect your beneficial bacteria, and which strategies really make a difference based on the research. Lindsey Parsons, your host, helps clients solve gut issues and reverse autoimmune disease naturally. Take her quiz to see which stool or functional medicine test will help you find out what's wrong. She's a Certified Health Coach at High Desert Health in Tucson, Arizona. She coaches clients locally and nationwide. You can also follow Lindsey on Facebook, Tiktok, X, Instagram or Pinterest or reach her via email at lindsey@highdeserthealthcoaching.com to set up your free 30-minute Gut Healing Breakthrough Session. Show Notes

In this episode, we explore new treatments for hypertension, hereditary amyloidosis, and malaria prevention, along with insights on mosquito-borne disease control. We review idiopathic intracranial hypertension, follow a striking case of a hidden foreign body, and hear perspectives on worker safety, immigrant health care, the role of pharmaceutical wholesalers, and the arc of a medical career.